Construction of Chimeric Human Epidermal Growth Factor Containing Short Collagen-Binding Domain Moieties for Use as a Wound Tissue Healing Agent
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Among the various human growth factors, epidermal growth factor (hEGF, consisting of 53 amino acids) has various effects on cell regeneration, stimulation of proliferation, migration of keratinocytes, formation of granulation tissues, and stimulation of fibroblast motility, which are important for wound healing. Owing to their multiple activities, EGFs are used as pharmaceutical and cosmetic agents. However, their low productivity, limited target specificity, and short half-life inhibit their application as therapeutic agents. To overcome these obstacles, we fused the collagen-binding domain (CBD) of Vibrio mimicus metalloprotease to EGF protein. About 18 or 12 amino acids (aa) (of the 33 total amino acids), which were essential for collagen-binding activity, were combined with the N- and C-termini of EGF. We constructed, expressed, and purified EGF (53 aa)-CBD (18 aa), EGF (53 aa)-CBD (12 aa), CBD (18 aa)-EGF (53 aa), and CBD (12 aa)-EGF (53 aa). These purified recombinant proteins increased the numbers of cells in treated specimens compared with non-treated specimens and control hEGF samples. The collagen-binding activities were also evaluated. Furthermore, CBD-hybridized hEGF induced phosphorylation of the EGF receptor. These results suggested that these fusion proteins could be applicable as small therapeutic agents in wound tissue healing.
Abstract
Among the various human growth factors, epidermal growth factor (hEGF, consisting of 53 amino acids) has various effects on cell regeneration, stimulation of proliferation, migration of keratinocytes, formation of granulation tissues, and stimulation of fibroblast motility, which are important for wound healing. Owing to their multiple activities, EGFs are used as pharmaceutical and cosmetic agents. However, their low productivity, limited target specificity, and short half-life inhibit their application as therapeutic agents. To overcome these obstacles, we fused the collagen-binding domain (CBD) of Vibrio mimicus metalloprotease to EGF protein. About 18 or 12 amino acids (aa) (of the 33 total amino acids), which were essential for collagen-binding activity, were combined with the N- and C-termini of EGF. We constructed, expressed, and purified EGF (53 aa)-CBD (18 aa), EGF (53 aa)-CBD (12 aa), CBD (18 aa)-EGF (53 aa), and CBD (12 aa)-EGF (53 aa). These purified recombinant proteins increased the numbers of cells in treated specimens compared with non-treated specimens and control hEGF samples. The collagen-binding activities were also evaluated. Furthermore, CBD-hybridized hEGF induced phosphorylation of the EGF receptor. These results suggested that these fusion proteins could be applicable as small therapeutic agents in wound tissue healing.
참고문헌 (25)
- Carpenter G, "125I-labeled human epidermal growth factor. Binding internalization, and degradation in human fibroblast", J. Cell Biol, 71, pp.159~171 (1976)
- Carpenter G, "Epidermal growth factor", Ann. Rev. Biochem, 48, pp.193~216 (1979)
- Chen X, "Enhanced production of human epidermal growth factor by a recombinant Escherichia coli integrated with in situ exchange of acetic acid by macroporous ion-exchange resin", J. Biosci. Bioeng, 5, pp.579~581 (2005)
- Chung KH, "Stabilization of epidermal growth factor on thermal and proteolytic degradation by conjugation with low molecular weight chitosan", J. Appl. Polym. Sci, 102, pp.5072~5082 (2006)
- Dagmar P, "Endotoxin removal from protein solution", J. Biotechnol, 76, pp.97~119 (2000)
- Egawa EY, "Enhanced proliferation of neural stem cells in a collagen hydrogel incorporating engineered epidermal growth factor", Biomaterials, 32, pp.4737~4743 (2011)
- Elloumi I, "Construction of epidermal growth factor fusion protein with cell adhesive activity", Biomaterials, 27, pp.3451~3458 (2006)
- Elloumi HI, "Construction of multifunctional proteins for tissue engineering:epidermal growth factor with collagen binding and cell adhesive activities", J. Biotechnol, 139, pp.19~25 (2009)
- Hardwicke J, "Epidermal growth factor therapy and wound healing – past, present and future perspective", Surgeon, 6, pp.172~177 (2008)
- Hayashi M, "Production of EGF-collagen chimeric protein which shows the mitogenic activity", Biochem. Biophys. Acta, 1528, pp.187~195 (2001)
- Imanishi J, "Growth factors: importance in wound healing and maintenance of transparence of the cornea", Prog. Retin. Eye Res, 19, pp.113~129 (2000)
- Ishikawa T, "Production of a biologically active epidermal growth factor fusion protein with high collagen affinity", J. Biochem, 129, pp.627~633 (2001)
- Ishikawa T, "Delivery of a growth factor fusion protein having collagen-binding activity to wound tissues", Artif. Organs, 27, pp.147~154 (2003)
- Kim DG, "Expression of a fusion protein containing human epidermal growth factor and the collagen-binding domain of Vibrio mimicus", Biotechnol. Lett, 31, pp.259~264 (2009)
- Kitajima T, "A chimeric epidermal growth factor with fibrin affinity promotes repair of injured keratinocyte sheets", Acta Biomater, 5, pp.2623~2632 (2009)
- Lee JH, "The FAXWXXT motif in the carboxyl terminus of Vibrio mimicus metalloprotease is involved in binding to collagen", FEBS Lett, 579, pp.2507~2513 (2005)
- Liu YL, "Secretion of biologically active human epidermal growth factor from Escherichia coli using Yersinia pestis Caf1signal peptide", J. Microbiol. Immunol. Infect, 39, pp.366~371 (2006)
- Nakagawa S, "Biological effects of biosynthetic human EGF on the growth of mammalian cell in vitro", Differentiation, 29, pp.284~288 (1985)
- Nimni ME, "Polypeptide growth factors: targeted delivery systems", Biomaterials, 18, pp.1201~1225 (1997)
- Nishi N, "Collagen-binding growth factors: production and characterization of functional fusion protein having a collagen-binding domain", Proc. Natl. Acad. Sci. USA, 95, pp.7018~7023 (1998)
- Rustad KC, "Strategies for organ level tissue engineering", Organogenesis, 6, pp.151~157 (2010)
- Sahasrabuddhe AA, "Stress-induced phosphorylation of caveolin-1 and p38, and down-regulation of EGFr and ERK by the dietary lectin jacalin in two human carcinoma cell lines", Cell Stress Chaperones, 11, pp.135~147 (2006)
- Schlessinger J, "Regulation of cell proliferation by epidermal growth factor", CRC Crit. Rev. Biochem, 14, pp.93~111 (1983)
- Yang Y, "Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds", Tissue Eng. A, 15, pp.3589~3596 (2009)
- Yin J, "Woundinduced ATP release and EGF receptor activation in epidermal cells", J. Cell Sci, 120, pp.815~825 (2007)